(Q37714089)

22 August 2017

1 reference

title

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases (English)

1 reference

progressive multifocal leukoencephalopathy

22 August 2017

0 references

0 references

0 references

5

Gavin Giovannoni

1 reference

22 August 2017

4

Gabriele Arendt

1 reference

22 August 2017

David B Clifford

1

1 reference

22 August 2017

Andrea De Luca

series ordinal

2

1 reference

22 August 2017

David M Simpson

series ordinal

3

1 reference

22 August 2017

Avindra Nath

series ordinal

6

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

9

1 reference

22 August 2017

4

1 reference

22 August 2017

438-446

1 reference

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Opportunistic infections and other risks with newer multiple sclerosis therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Identification and characterization of mefloquine efficacy against JC virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Determinants of survival in progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Asymptomatic reactivation of JC virus in patients treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Asymptomatic reactivation of JC virus in patients treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Seroepidemiology of human polyomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970028-4

7 January 2021

10.1016/S1474-4422(10)70028-4

Identifiers

DOI

1 reference

release_2joktthxorbczbptcez7zdwmgy

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2joktthxorbczbptcez7zdwmgy

24 November 2022

mapped directly with Wikidata item

1 reference